Krebs Biochemicals & Industries Ltd Dividend

Krebs Biochemicals & Industries Ltd Dividend - Payout, Yield & Future Updates

Image

Krebs Biochemicals & Industries Ltd

NSE: KREBSBIO

Dividend Payout (-)

-

Ex-Dividend Date: NA

Krebs Biochemicals & Industries Ltd Dividend - History

swot
swot

Monitoring Krebs Biochemicals & Industries Ltd share price can help you stay informed about potential market shifts and opportunities.

Dividend Payout Over Time

No data available

Overview of Dividend

  • <h2><strong>Types of Dividend</strong></h2><br> <h3>Special Dividend</h3> <p>A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.</p> <br> <h3>Preferred Dividend</h3> <p>A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.</p> <br> <h3>Interim Dividend</h3> <p>Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.</p> <br> <h3>Final Dividend</h3> <p>A final dividend is issued after the year's accounts have been compiled.
  • Aside from this, the following list highlights the most prevalent sorts of dividends:</p> <br>.

Types of Dividend


Special Dividend

A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.


Preferred Dividend

A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.


Interim Dividend

Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.


Final Dividend

A final dividend is issued after the year's accounts have been compiled. Aside from this, the following list highlights the most prevalent sorts of dividends:


Dividend Yield Comparison With Top Peers

* All values are in %

Image

Krebs Biochemicals & Industries Ltd

NSE: KREBSBIO

Share Price

₹ -

Last updated on: Jan 01, 2026

Company Fundamentals for Krebs Biochemicals & Industries Ltd

Dividend Payout Over Time

No data available

Net Profit Vs Dividend Per Share

SWOT Analysis Of Krebs Biochemicals & Industries Ltd

Strength

0

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Krebs Biochemicals & Industries Ltd

Historical Market Cap of Krebs Biochemicals & Industries Ltd

Market Cap

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Krebs Biochemicals & Industries Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Krebs Biochemicals & Industries Ltd News Hub

Krebs Biochemicals & Industries reports standalone net loss of Rs 5.17 crore in the June 2024 quarter

Net Loss of Krebs Biochemicals & Industries reported to Rs 5.17 crore in the quarter ended June 2024

Read more

07 Aug 24

Krebs Biochemicals & Industries schedules AGM

Krebs Biochemicals & Industries announced that the 32th Annual General Meeting (AGM) of the company

Read more

09 Sept 24

Krebs Biochemicals & Industries to conduct board meeting

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 11 N

Read more

29 Oct 24

Krebs Biochemicals & Industries reports standalone net loss of Rs 5.76 crore in the September 2024 quarter

Net Loss of Krebs Biochemicals & Industries reported to Rs 5.76 crore in the quarter ended September

Read more

11 Nov 24

About Krebs Biochemicals & Industries Ltd

  • Krebs Biochemicals & Industries Ltd (Formerly Krebs Biochemicals Ltd), promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same. Krebs develops commercially viable biotech processes for application in medicine, agriculture and industry.
  • Undertaking contract manufacturing for large pharmaceutical and multinational companies and developing products for sale in global markets, the Company possesses expertise and infrastructure in chemical synthesis, fermentation and enzymatic technologies. KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA. KBL went to public with an IPO in 1994. During 2001-02, the company launched Vitamin C(I P Grade) through Fermentation Process.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions